Paid Clinical Trials in Palm Bay, FL
As of August 2026, 19 paid clinical trials are recruiting in Palm Bay, Florida. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Palm Bay offers studies at sites including Cancer Care Centers of Brevard, Inc. for conditions such as Carcinoma, Non-Small-Cell Lung, Non-Small Cell Lung Cancer, Breast Cancer, Major Depressive Disorder. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Palm Bay
Trials by drug in Palm Bay
Filter results
Newly added in Palm Bay
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
18 clinical trials
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
MYLUNG Consortium Part 3: Observational Study
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
Top Research Study Locations in Palm Bay
Researchers run research studies in Palm Bay, FL at 8 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Cancer Care Centers of Brevard, Inc. | Carcinoma, Non-Small-Cell Lung, Advanced Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung (NSCLC) | 5 |
| Cancer Care Centers of Brevard, Inc | Advanced Breast Cancer, Breast Cancer, Breast Neoplasms | 4 |
| Neurocrine Clinical Site | Major Depressive Disorder | 2 |
| Seaport Investigator Site | Major Depressive Disorder (MDD), Major Depressive Disorder With Anxious Distress | 2 |
| Cancer Care Centers of Brevard | Limited Stage Small Cell Lung Cancer | 1 |
| Cancer Care Centers of Brevard (CCCB) - Palm Bay | Breast Cancer | 1 |
| Cancer Care of Brevard | Non-Small Cell Lung Cancer | 1 |
| Local Institution - 0519 | Non-Small Cell Lung Cancer | 1 |
Active & Upcoming Studies in Palm Bay (2026)
Recruiting trials in Palm Bay grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (13 active studies)
- Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02) · Phase 3 · Bristol-Myers Squibb
- Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer · Phase 3 · Pfizer
Common conditions studied in Palm Bay
- Carcinoma, Non-Small-Cell Lung (3 active studies)
- Non-Small Cell Lung Cancer (3 active studies)
- Breast Cancer (2 active studies)
- Major Depressive Disorder (2 active studies)
- Major Depressive Disorder (MDD) (2 active studies)
- Major Depressive Disorder With Anxious Distress (2 active studies)
Leading research sponsors in Palm Bay
- Pfizer
- BioNTech SE
- Neurocrine Biosciences
- Seaport Therapeutics
- AstraZeneca
Frequently asked questions
How many paid clinical trials are currently recruiting in Palm Bay?
There are approximately 19 recruiting clinical trials in Palm Bay, Florida listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Palm Bay pay participants?
Most recruiting trials in Palm Bay compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Palm Bay?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Palm Bay?
The most common conditions under active study in Palm Bay include Carcinoma, Non-Small-Cell Lung (3), Non-Small Cell Lung Cancer (3), Breast Cancer (2), Major Depressive Disorder (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Palm Bay?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Palm Bay on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Palm Bay?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Palm Bay?
Recruiting research sites in Palm Bay include Cancer Care Centers of Brevard, Inc., Cancer Care Centers of Brevard, Inc, Neurocrine Clinical Site, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Palm Bay right now?
The largest active categories in Palm Bay are Cancer & tumors (13). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.